Home > Boards > US Listed > Biotechs > Portola Phramaceuticals (PTLA)

Buying oppurtunity? Slow drift on no news. Almost May....Glta.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
ACTcrazy Member Profile
 
Followed By 2
Posts 194
Boards Moderated 0
Alias Born 03/23/14
160x600 placeholder
Portola Pharmaceuticals to Announce Third Quarter 2019 Financial Results on Tuesday, November 5, 2019 PR Newswire (US) - 10/15/2019 8:30:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/2/2019 4:21:37 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 10/2/2019 4:17:31 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/23/2019 6:33:32 AM
Portola Pharmaceuticals Appoints Ted W. Love, M.D., to its Board of Directors PR Newswire (US) - 9/19/2019 8:20:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/5/2019 7:06:39 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/5/2019 7:03:49 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/3/2019 6:05:36 PM
Portola Pharmaceuticals to Participate in Two Upcoming Investor Conferences PR Newswire (US) - 8/22/2019 8:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/14/2019 4:20:36 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 8/14/2019 4:15:44 PM
Portola Pharmaceuticals Announces Pricing of Public Offering of Common Stock PR Newswire (US) - 8/13/2019 7:32:00 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 8/12/2019 4:46:55 PM
Portola Pharmaceuticals Announces Proposed Offering of Common Stock PR Newswire (US) - 8/12/2019 4:43:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/9/2019 6:51:55 PM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 8/7/2019 5:16:00 PM
Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (s-3asr) Edgar (US Regulatory) - 8/7/2019 5:12:36 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/7/2019 4:32:57 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/7/2019 4:13:13 PM
Portola Pharmaceuticals Reports Second Quarter 2019 Financial Results and Provides Corporate Update PR Newswire (US) - 8/7/2019 4:05:00 PM
Portola Launches European Sales of Ondexxya® (Andexanet Alfa) with First Orders in Europe PR Newswire (US) - 8/6/2019 8:30:00 AM
U.S. Centers for Medicare and Medicaid Services (CMS) Increases New Technology Add-On Payment (NTAP) Reimbursement for Portol... PR Newswire (US) - 8/5/2019 7:00:00 AM
Portola Pharmaceuticals to Announce Second Quarter 2019 Financial Results on Wednesday, August 7, 2019 PR Newswire (US) - 7/17/2019 8:30:00 AM
Portola Pharmaceuticals Presents New In Vitro Data Demonstrating that Four-Factor Prothrombin Complex Concentrates (4F-PCCs) ... PR Newswire (US) - 7/8/2019 8:30:00 AM
Portola Presents New Interim Data on its Oral SYK/JAK Inhibitor Cerdulatinib in Heavily Pre-Treated Patients with Relapsed/Re... PR Newswire (US) - 6/19/2019 11:05:00 AM
ACTcrazy   Monday, 04/15/19 09:56:46 PM
Re: ACTcrazy post# 175
Post # of 182 
Buying oppurtunity? Slow drift on no news. Almost May....Glta.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist